{"id":2450,"date":"2024-08-26T19:35:18","date_gmt":"2024-08-26T19:35:18","guid":{"rendered":"https:\/\/cep.health\/e2p\/?page_id=2450"},"modified":"2025-09-10T19:20:39","modified_gmt":"2025-09-10T19:20:39","slug":"sickle-cell-disease","status":"publish","type":"page","link":"https:\/\/cep.health\/e2p\/acute-care-tools\/sickle-cell-disease\/","title":{"rendered":"\u00a0Sickle Cell Disease"},"content":{"rendered":"\n
\n
\n

Sickle Cell Disease (SCD) is a group of inherited red blood cell disorders that cause severe body pain and damage. More than 3,500 Ontarians are living with the incurable disease, which primarily affects Black and racialized people from Africa, the Caribbean Mediterranean, the Middle East, South America and South Asia. However, many people with SCD experience delayed care, misdiagnosis and undertreatment, due to inconsistent approaches to treatment, lack of training and systemic racism.<\/p>\n\n\n\n

SCD is a priority topic and a new use case within the E2P program for acute care hospitals.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>
\n
Spotlight: Digital Tools Enhance SCD Care in Ontario Hospitals<\/strong><\/h5>\n<\/div><\/div>\n\n\n\n

A recent Ontario Hospital Association feature highlights how North York General, through the provincial E2P initiative, is embedding the latest SCD quality standards directly into hospital systems – dramatically speeding up adoption from years to just four to six months. These digital enhancements ensure rapid, evidence-based triage and treatment, improve clinical consistency, and facilitate culturally sensitive care for SCD patients, many of whom face systemic inequities and stigma.<\/p>\n\n\n\n

\n
Click here to read the full OHA article to learn how E2P’s digital-first strategies are transforming acute care for patients with SCD across Ontario.<\/strong><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

Benefits for Participating Hospitals<\/strong><\/h3>\n\n\n\n